Chief Medical Officer (CMO), Co-Founder

A clinical neurologist with over 40 years of experience, he is a global reference in the diagnosis and clinical research of Multiple Sclerosis. He has participated in more than 100 clinical trials and published over 250 articles in indexed scientific journals. Former Head of Neurology and Director of the Clinical Neurosciences Institute at the Regional University Hospital of Málaga, he has also chaired Spain’s Multiple Sclerosis Medical Advisory Committee and served on the boards of both the Andalusian and Spanish Neurology Societies. He is currently a trustee of the European Charcot Foundation and co-inventor of the patents behind ALA Diagnostics, where he has been involved since the project’s inception.

General Manager, Co-Founder

Pharmacist with a Master’s degree in Biotechnology Business Management, he has 19 years of experience in the biotech sector. His expertise includes R&D project management, feasibility analysis, business planning, and strategic consulting for biotech start-ups. In 2008, he co-founded Innovative Bioconsulting, a strategic consultancy firm specialized in biotechnology, where he leads company management, client acquisition, and project portfolio oversight. Since 2019, he has also served as CEO and Chairman of the Board at ALA Diagnostics.